Metoprolol tartrate is indicated for the treatment of hypertension in adult patients, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Easy-to-read patient tips for metoprolol-tartrate covering how it works, benefits, risks, and best practices. Metoprolol is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. Overview: Metoprolol is a beta blocker. It is is used to treat high blood pressure, chest pain, heart failure, and lower the risk of a repeat heart attack. Common side effects include tiredness. Metoprolol (Lopressor®) is a medication that lowers your blood pressure and heart rate, making it easier for your heart to pump blood to the rest of your body. Acute Myocardial Infarction Metoprolol tartrate is used orally and IV to reduce the risk of cardiovascular mortality in hemodynamically stable patients with definite or suspected acute MI. The term MI is used when there is evidence of myocardial necrosis in the setting of acute myocardial ischemia. [807] Metoprolol tartrate is used in people whose blood pressure and circulation are stable after a definite or suspected heart attack, to reduce the risk of dying from heart and blood vessel causes. In hospital, it may be started as an injection into a vein and then continued as tablets. Read on to learn about the side effects of metoprolol, including common, severe, and long-term side effects, and how to manage them. Lopressor (metoprolol tartrate) Tablets and Injection is a selective beta-adrenoreceptor blocking agent (beta-blocker) used to treat high blood presure (hypertension), angina, and heart attacks. The specific agent in on-market formulations of metoprolol is either metoprolol tartrate or metoprolol succinate, where tartrate is an immediate-release formulation and the succinate is an extended-release formulation (with 100 mg metoprolol tartrate corresponding to 95 mg metoprolol succinate).